Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Highly selective inhibitors of protein kinases CLK and HIPK with the furo[3,2-b]pyridine core
Václav Nêmec, Lukáš Maier, Benedict‐Tilman Berger, et al.
European Journal of Medicinal Chemistry (2021) Vol. 215, pp. 113299-113299
Closed Access | Times Cited: 24

Showing 24 citing articles:

Pyridine Scaffolds, Phenols and Derivatives of Azo Moiety: Current Therapeutic Perspectives
Tehreem Tahir, Muhammad Ashfaq, Muhammad Saleem, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4872-4872
Open Access | Times Cited: 61
Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases
Mengqiu Song, L. Pang, Mengmeng Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 36
Host-guest doped room/high-temperature phosphorescence of diarylfuro[3,2-b]pyridine derivatives
Yuzhe Wang, Wenbo Dai, Xiaoyu Qiu, et al.
Chemical Engineering Journal (2024) Vol. 489, pp. 150919-150919
Closed Access | Times Cited: 13
Mild and efficient synthesis and base-promoted rearrangement of novel isoxazolo[4,5-b]pyridines
Vladislav V. Nikol’skiy, Mikhail E. Minyaev, Maxim A. Bastrakov, et al.
Beilstein Journal of Organic Chemistry (2024) Vol. 20, pp. 1069-1075
Open Access | Times Cited: 4
Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation
Ines H. Kaltheuner, K. Anand, Jonas Moecking, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Biology and pharmacological inhibition of homeodomain-interacting protein kinases
Adam Štefek, Kamil Paruch
Frontiers in Chemical Biology (2025) Vol. 4
Open Access
Development of Cdc2-like Kinase 2 Inhibitors: Achievements and Future Directions
Zhen Qin, Lian Qin, Xi Feng, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13191-13211
Closed Access | Times Cited: 15
Organic doped red room-temperature afterglow materials based on 2,3,5-triarylfuro[3,2-b]pyridines through Förster-resonance energy transfer
Yuzhe Wang, Huaiying Huang, Q. S. Liu, et al.
Chemical Engineering Journal (2024) Vol. 499, pp. 156584-156584
Closed Access | Times Cited: 2
Synthesis, kinetics, structure-activity relationship and in silico ADME studies of new diazenyl azo-phenol derivatives against urease, SARS-CoV-2 main protease (Mpro) and ribosomal protein S1 (RpsA) of Mycobacterium tuberculosis
Tehreem Tahir, Rukhsana Tabassum, Qamer Javed, et al.
Journal of Molecular Structure (2022) Vol. 1254, pp. 132336-132336
Closed Access | Times Cited: 9
Exploring Chemistry with Pyridine Derivatives

IntechOpen eBooks (2022)
Open Access | Times Cited: 7
MSC-1186, a Highly Selective Pan-SRPK Inhibitor Based on an Exceptionally Decorated Benzimidazole-Pyrimidine Core
Martin Schröder, Matthias Leiendecker, Ulrich Grädler, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 837-854
Closed Access | Times Cited: 7
Recent Advances in the Development of HIPK2 Inhibitors As anti-renal Fibrosis Agents
Chao Hao, Meng Cao, Hanyi Ouyang, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 5, pp. 453-465
Closed Access | Times Cited: 4
Discovery of Two Highly Selective Structurally Orthogonal Chemical Probes for Activin Receptor-like Kinases 1 and 2
Václav Nêmec, Marek Remeš, Petr Beňovský, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 12632-12659
Open Access | Times Cited: 1
Furo[3,2-b]pyridine: Chemical synthesis, transformations and biological applications
Sumayya Akram, Sana Aslam, Nasır Rasool, et al.
Journal of Saudi Chemical Society (2024) Vol. 28, Iss. 5, pp. 101906-101906
Open Access | Times Cited: 1
Discovery of CLKs Inhibitors for the Treatment of Non-small Cell Lung Cancer
Tianxing Hu, Jiali Huang, Rui Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116952-116952
Closed Access | Times Cited: 1
Virtual Screening, Molecular Dynamics, and Mechanism Study of Homeodomain-Interacting Protein Kinase 2 Inhibitor in Renal Fibroblasts
Xinlan Hu, Yan Wu, Hanyi Ouyang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1420-1420
Open Access | Times Cited: 1
An efficient strategy for synthesis of new functionalized furo[3,2‐c]pyridin‐4(5H)‐one derivatives under mild conditions
Jiahao Tao, Chunmei Li, Kaini Zhou, et al.
Journal of Heterocyclic Chemistry (2022) Vol. 59, Iss. 10, pp. 1742-1751
Closed Access | Times Cited: 5
Phosphoproteomics Unravel HBV Triggered Rewiring of Host Phosphosignaling Events
Zijie Lim, Nur Khairiah Mohd-Ismail, Evelyn Png, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5127-5127
Open Access | Times Cited: 4
Investigation of Solvent Effect and H-Bonding on Spectroscopic Properties of 1-(3-Amino-6-(2,5-dichlorothiophen-3-yl)-4-phenylfuro[2,3-b]Pyridin-2-yl) Ethenone: Experimental and Computational Study
Rasha Abuflaha, Fakhri O. Yousef, Raed Ghanem, et al.
Journal of Fluorescence (2023) Vol. 33, Iss. 6, pp. 2349-2360
Open Access | Times Cited: 1
Thieno[3,2‐b]pyridine: Attractive scaffold for highly selective inhibitors of underexplored protein kinases with variable binding mode
Paula Martín Moyano, Tadeáš Kubina, Štěpán Owen Paruch, et al.
Angewandte Chemie International Edition (2024) Vol. 64, Iss. 1
Open Access
Thieno[3,2‐b]pyridine: Attractive scaffold for highly selective inhibitors of underexplored protein kinases with variable binding mode
Paula Martín Moyano, Tadeáš Kubina, Štěpán Owen Paruch, et al.
Angewandte Chemie (2024) Vol. 137, Iss. 1
Open Access
Fused Pyridine Derivatives: Synthesis and Biological Activities
Hüseyin İstanbullu, Gülşah Bayraktar, Merve Saylam
IntechOpen eBooks (2022)
Open Access | Times Cited: 2
Cellular selectivity and kinetics of clinical kinase inhibitors
Lena M. Berger
(2023)
Open Access
Quantum chemical, spectroscopic and molecular docking investigations of potential pulmonary fibrosis drug methyl 2‐chloro 4‐iodonicotinate
G. Pandimeena, T. Mathavan, E. James Jebaseelan Samuel, et al.
Journal of Molecular Recognition (2022) Vol. 36, Iss. 2
Closed Access
Page 1

Scroll to top